214 related articles for article (PubMed ID: 24252548)
1. Novel agents in development for the treatment of depression.
Grady MM; Stahl SM
CNS Spectr; 2013 Dec; 18 Suppl 1():37-40; quiz 41. PubMed ID: 24252548
[TBL] [Abstract][Full Text] [Related]
2. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
Budziszewska B
Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
Maric NP; Adzic M
Psychiatr Danub; 2013 Sep; 25(3):299-305. PubMed ID: 24048401
[TBL] [Abstract][Full Text] [Related]
4. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G
Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
[TBL] [Abstract][Full Text] [Related]
5. Use of endocrine hormones for treating depression.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Dec; 48(12):13-6. PubMed ID: 21117521
[TBL] [Abstract][Full Text] [Related]
6. The hypothalamic-pituitary-adrenocortical (HPA) system and anti-depressive drug (AD) action.
Reul JM; Söder M; Holsboer F
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():584A-585A. PubMed ID: 1498962
[No Abstract] [Full Text] [Related]
7. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
Barden N; Reul JM; Holsboer F
Trends Neurosci; 1995 Jan; 18(1):6-11. PubMed ID: 7535490
[TBL] [Abstract][Full Text] [Related]
8. Regulation of corticosteroid receptor gene expression in depression and antidepressant action.
Barden N
J Psychiatry Neurosci; 1999 Jan; 24(1):25-39. PubMed ID: 9987205
[TBL] [Abstract][Full Text] [Related]
9. [The role of the hypothalamo-hypophyseal-adrenocortical system in the specific activity of antidepressive agents].
Arushanian EB; El'bek'ian KS
Eksp Klin Farmakol; 1995; 58(3):65-70. PubMed ID: 7663305
[TBL] [Abstract][Full Text] [Related]
10. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
11. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis.
File SE
Pharmacol Ther; 1990; 46(3):357-75. PubMed ID: 1971443
[TBL] [Abstract][Full Text] [Related]
12. [Biological factors and resistance to antidepressive agents].
Puech AJ; Corruble E
Encephale; 1995 Mar; 21 Spec No 2():17-21. PubMed ID: 7588173
[TBL] [Abstract][Full Text] [Related]
13. The design of new antidepressants: can formal models help? A first attempt using a model of the hippocampal control over the HPA-axis based on a review from the literature.
Belzung C; Billette de Villemeur E
Behav Pharmacol; 2010 Dec; 21(8):677-89. PubMed ID: 21051994
[TBL] [Abstract][Full Text] [Related]
14. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
15. Pathobiological targets of depression.
Chopra K; Kumar B; Kuhad A
Expert Opin Ther Targets; 2011 Apr; 15(4):379-400. PubMed ID: 21254923
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrinological mechanisms of actions of antidepressant drugs.
Schüle C
J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
[TBL] [Abstract][Full Text] [Related]
17. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants and pain.
Micó JA; Ardid D; Berrocoso E; Eschalier A
Trends Pharmacol Sci; 2006 Jul; 27(7):348-54. PubMed ID: 16762426
[TBL] [Abstract][Full Text] [Related]
19. [Neurobiological mechanisms of depression and antidepressant therapy].
Shishkina GT; Dygalo NN
Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(2):138-52. PubMed ID: 20469588
[TBL] [Abstract][Full Text] [Related]
20. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
Twardowska K; Rybakowski J
Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
